Compare ARK Genomic Revolution ETF (ARKG) vs Xpeng Inc - ADR (XPEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Xpeng Inc - ADR — how do they compare? ARK Genomic Revolution ETF trades at $40.78, while Xpeng Inc - ADR trades at $12.91 (market cap $12.50B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Xpeng Inc - ADR nearer its low. Which is the better fit depends on your goals.
| ARKG | XPEV | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $28.07 |
52-Week Low | $23.09 | $12.09 |
Market Cap | — | $12.50B |
Enterprise Value | — | $14.62B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XPEV trades at $13.03, up 0.39% on the day, with a bearish technical signal and neutral oscillators. The company reported Q2 2026 revenue of $73.9B but a net loss of $2.3B, continuing negative profitability trends. Recent news highlights include Robotaxi testing and European market expansion, while analyst consensus remains 64.7% buy despite cash flow challenges.
Outlook is mixed: growth in autonomous driving and international markets offers upside, but persistent losses and competitive pressures pose significant risks. Investors should weigh innovation potential against financial sustainability in the volatile EV sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →
